305 related articles for article (PubMed ID: 6253785)
1. Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.
Stewart AF; Horst R; Deftos LJ; Cadman EC; Lang R; Broadus AE
N Engl J Med; 1980 Dec; 303(24):1377-83. PubMed ID: 6253785
[TBL] [Abstract][Full Text] [Related]
2. Calcium homeostasis in immobilization: an example of resorptive hypercalciuria.
Stewart AF; Adler M; Byers CM; Segre GV; Broadus AE
N Engl J Med; 1982 May; 306(19):1136-40. PubMed ID: 6280047
[TBL] [Abstract][Full Text] [Related]
3. The multiple causes of hypercalcemia in malignant disease.
Sherwood LM
N Engl J Med; 1980 Dec; 303(24):1412-3. PubMed ID: 6253787
[No Abstract] [Full Text] [Related]
4. Stimulation of calcium reabsorption observed in advanced breast cancer patients with hypercalcemia and multiple bone metastases.
Kimura S; Adchi I; Yamaguchi K; Suzuki M; Shimada A; Sato Y; Nagaoka K; Abe K
Jpn J Cancer Res; 1985 Apr; 76(4):308-14. PubMed ID: 2989061
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of the parathyroid hormone-1,25-dihydroxyvitamin D axis to variations in calcium intake in patients with primary hyperparathyroidism.
Insogna KL; Mitnick ME; Stewart AF; Burtis WJ; Mallette LE; Broadus AE
N Engl J Med; 1985 Oct; 313(18):1126-30. PubMed ID: 2995810
[TBL] [Abstract][Full Text] [Related]
6. [Primary hyperparathyroidism. Current aspects of its diagnosis apropos of a case with digestive and neuropsychiatric manifestations].
Sebert JL; Dupont A; Fournier A; Coevoet B; Lambrey G; Ghighi J; Quichaud J
Sem Hop; 1978 Dec 18-25; 54(45-46):1488-93. PubMed ID: 219510
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandins as mediators of hypercalcemia associated with certain types of cancer.
Seyberth HW; Segre GV; Morgan JL; Sweetman BJ; Potts JT; Oates JA
N Engl J Med; 1975 Dec; 293(25):1278-83. PubMed ID: 1186822
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of hypercalcemia in patients with head and neck cancer.
Angel MF; Stewart A; Pensak ML; Pillsbury HR; Sasaki CT
Head Neck Surg; 1982; 5(2):125-9. PubMed ID: 7169331
[TBL] [Abstract][Full Text] [Related]
9. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
[TBL] [Abstract][Full Text] [Related]
10. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer.
Burtis WJ; Brady TG; Orloff JJ; Ersbak JB; Warrell RP; Olson BR; Wu TL; Mitnick ME; Broadus AE; Stewart AF
N Engl J Med; 1990 Apr; 322(16):1106-12. PubMed ID: 2320080
[TBL] [Abstract][Full Text] [Related]
11. Immobilisation hypercalcemia.
Evans RA; Bridgeman M; Hills E; Dunstan CR
Miner Electrolyte Metab; 1984; 10(4):244-8. PubMed ID: 6087102
[TBL] [Abstract][Full Text] [Related]
12. Nephrogenous cyclic AMP, adenylate cyclase-stimulating activity, and the humoral hypercalcemia of malignancy.
Godsall JW; Burtis WJ; Insogna KL; Broadus AE; Stewart AF
Recent Prog Horm Res; 1986; 42():705-50. PubMed ID: 3016837
[No Abstract] [Full Text] [Related]
13. Urinary cyclic AMP as an aid in the differential diagnosis of hypercalcemia.
Debacker M; Manderlier T; Nijs-Dewolf N; Six R; Corvilain J
Biomedicine; 1974 Aug; 21(8):338-41. PubMed ID: 4374265
[No Abstract] [Full Text] [Related]
14. Ectopic secretion of parathyroid hormone.
Max MH; Lawrence PH
Surg Gynecol Obstet; 1980 Mar; 150(3):411-8. PubMed ID: 6986669
[TBL] [Abstract][Full Text] [Related]
15. Urinary cyclic AMP analyzed as a function of the serum calcium and parathyroid hormone in the idfferential diagnosis of hypercalcemia.
Shaw JW; Oldham SB; Rosoff L; Bethune JE; Fichman MP
J Clin Invest; 1977 Jan; 59(1):14-21. PubMed ID: 187621
[TBL] [Abstract][Full Text] [Related]
16. Impaired production and decreased urinary excretion of adenosine 3',5'-monophosphate in primary hyperparathyroidism with vitamin D deficiency.
Rubinger D; Friedlaender MM; Silver J; Wald H; Shumart T; Popovtzer MM
Miner Electrolyte Metab; 1988; 14(5):283-7. PubMed ID: 2845240
[TBL] [Abstract][Full Text] [Related]
17. Nephrogenous cyclic adenosine monophosphate as a parathyroid function test.
Broadus AE; Mahaffey JE; Bartter FC; Neer RM
J Clin Invest; 1977 Oct; 60(4):771-83. PubMed ID: 197123
[TBL] [Abstract][Full Text] [Related]
18. Differential diagnosis of hypercalcemia.
Lafferty FW
J Bone Miner Res; 1991 Oct; 6 Suppl 2():S51-9; discussion S61. PubMed ID: 1763670
[TBL] [Abstract][Full Text] [Related]
19. Nephrogenous cyclic adenosine monophosphate levels in normocalcemic cancer patients: its significance.
Abramson EC; Kukreja SC; Lad TE; Shemerdiak WP; York PA
Horm Metab Res; 1984 Apr; 16(4):204-7. PubMed ID: 6327481
[TBL] [Abstract][Full Text] [Related]
20. Effects of the intravenous administration of calcium on nephrogenous cyclic AMP: use as a parathyroid suppression test.
Broadus AE; Deftos LJ; Bartter FC
J Clin Endocrinol Metab; 1978 Mar; 46(3):477-87. PubMed ID: 221521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
